Growth Metrics

Novartis Ag (NVS) Return on Sales (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 1.00
Jun 30, 2022 -2.00
Mar 31, 2022 2.00
Dec 31, 2021 -3.00
Sep 30, 2021 3.00
Jun 30, 2021 -2.00
Mar 31, 2021 -18.00
Dec 31, 2020 18.00
Sep 30, 2020 2.00
Jun 30, 2020 -1.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 1.00
Sep 30, 2018 -1.00
Jun 30, 2018 0.00
Mar 31, 2018 -2.00
Dec 31, 2017 -1.00
Sep 30, 2017 -9.00
Dec 31, 2016 -3.00
Sep 30, 2016 -1.00
Jun 30, 2016 -978,834.00
Mar 31, 2016 978,838.00
Dec 31, 2015 -572.41 Bn
Mar 31, 2015 15.00
Dec 31, 2014 -13.00
Jun 30, 2010 40.00
Mar 31, 2010 -938,806.00
Dec 31, 2009 938,806.00
Sep 30, 2009 -232.00
Jun 30, 2009 231.00